نتائج البحث 591-600 من 20765 لعملية البحث عن WHO
... who have received at least two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for DLBCL. EF-41/KEYNOTE D58: Phase 3 Study ...
... who did not have cancer. The increased risk of HF is observed as early as one year from diagnosis of cancer and overall, 7% of patients develop CHF (median ...
Rochester, Minn. This clinical trial is studying long-term follow-up in patients who are or have participated in Children's Oncology Group studies. Developing a ...
... who failed at least two lines of therapy as measured by objective response rate (ORR) at one month. A Vaccine (H2NVAC) Before Surgery for the Treatment of ...
(i.e., who were not treated pre-surgically). HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers. Rochester, Minn., Mankato, Minn., La Crosse, ...
Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...
The purpose of this study is to compare the incidence of cuff dehiscence in patients who have undergone total robotic laparoscopic hysterectomy vs. total ...
Those who pass baseline screening will complete a blood draw and a series of cognitive and functional assessments at baseline. Participants will undergo in ...
... who have failed 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); ...
... who remain unimpaired at older ages due to unknown protective factors and spared pathophysiological effects despite their genetic risk. A Study to Evaluate ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.